Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1 LA Johnson, S Banerji, W Lawrance, U Gileadi, G Prota, KA Holder, ... Nature immunology 18 (7), 762-770, 2017 | 168 | 2017 |
Hepatitis C virus–infected cells downregulate NKp30 and inhibit ex vivo NK cell functions KA Holder, SN Stapleton, ME Gallant, RS Russell, MD Grant The Journal of Immunology 191 (6), 3308-3318, 2013 | 76 | 2013 |
Rapid Lymphatic Dissemination of Encapsulated Group A Streptococci via Lymphatic Vessel Endothelial Receptor-1 Interaction NN Lynskey, S Banerji, LA Johnson, KA Holder, M Reglinski, PAC Wing, ... PLoS pathogens 11 (9), e1005137, 2015 | 45 | 2015 |
Origins of natural killer cell memory: special creation or adaptive evolution KA Holder, EM Comeau, MD Grant Immunology 154 (1), 38-49, 2018 | 23 | 2018 |
Moderate to severe SARS-CoV-2 infection primes vaccine-induced immunity more effectively than asymptomatic or mild infection KA Holder, DP Ings, DOA Harnum, RS Russell, MD Grant NPJ vaccines 7 (1), 122, 2022 | 19 | 2022 |
TIGIT blockade enhances NK cell activity against autologous HIV‐1‐infected CD4+ T cells KA Holder, K Burt, MD Grant Clinical & Translational Immunology 10 (10), e1348, 2021 | 18 | 2021 |
TIGIT blockade: a multipronged approach to target the HIV reservoir KA Holder, MD Grant Frontiers in cellular and infection microbiology 10, 175, 2020 | 18 | 2020 |
Human cytomegalovirus IL-10 augments NK cell cytotoxicity KA Holder, MD Grant Journal of leukocyte biology 106 (2), 447-454, 2019 | 18 | 2019 |
Natural killer cell function and dysfunction in hepatitis C virus infection KA Holder, RS Russell, MD Grant BioMed research international 2014 (1), 903764, 2014 | 16 | 2014 |
Natural killer cells adapt to cytomegalovirus along a functionally static phenotypic spectrum in human immunodeficiency virus infection KA Holder, J Lajoie, MD Grant Frontiers in Immunology 9, 2494, 2018 | 14 | 2018 |
Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2Cnull Human Immunodeficiency Virus-Infected Individuals EM Comeau, KA Holder, NJ Fudge, MD Grant Viruses 11 (3), 239, 2019 | 12 | 2019 |
Few SARS-CoV-2 infections detected in Newfoundland and Labrador in the absence of Public Health Laboratory-based confirmation DP Ings, KM Hatfield, KE Fifield, DOA Harnum, KA Holder, RS Russell, ... Plos one 17 (1), e0262957, 2022 | 8 | 2022 |
Combined anti-S1 and anti-S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2 MD Grant, K Bentley, CA Fielding, KM Hatfield, DP Ings, D Harnum, ... JCI insight 8 (15), 2023 | 7 | 2023 |
Modulation of the strength and character of HIV-specific CD8+ T cell responses with heteroclitic peptides KA Holder, MD Grant AIDS Research and Therapy 14, 1-4, 2017 | 4 | 2017 |
Cellular Immune Responses to SARS-CoV-2 in Exposed Seronegative Individuals NJ Norton, KA Holder, DP Ings, DOA Harnum, RS Russell, MD Grant Viruses 15 (4), 996, 2023 | 3 | 2023 |
Characteristics of Vaccine-and Infection-Induced Systemic IgA Anti-SARS-CoV-2 Spike Responses NJ Norton, DP Ings, KE Fifield, DA Barnes, KA Barnable, DOA Harnum, ... Vaccines 11 (9), 1462, 2023 | 2 | 2023 |
Hybrid immunity elicits potent cross-variant ADCC against SARS-CoV-2 through a combination of anti-S1 and S2 antibodies MD Grant, K Bentley, CA Fielding, KM Hatfield, DP Ings, D Harnum, ... BioRxiv, 2023.03. 09.531709, 2023 | 1 | 2023 |
Progress towards World Health Organization HIV Infection 95-95-95 measures in Newfoundland and Labrador, Canada KA Holder, E Ding, D Kao, M Shokoohi, J Trigg, RS Hogg, J Morkar, ... PloS one 19 (6), e0305898, 2024 | | 2024 |
Antibody ‘Hotspots’ induce antibody-dependent cell-mediated cytotoxicity against SARS-CoV-2 spike-expressing lung fibroblasts K Holder, K Hatfield, D Ings, K Fifield, D Harnum, M Grant The Journal of Immunology 208 (1_Supplement), 50.21-50.21, 2022 | | 2022 |
The influence of TIGIT on natural killer cell activity against HIV K Holder, M Grant The Journal of Immunology 204 (1_Supplement), 95.12-95.12, 2020 | | 2020 |